البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
LOPERAMIDE HYDROCHLORIDE
J-C HEALTH CARE LTD
A07DA
CAPSULES
LOPERAMIDE HYDROCHLORIDE 2 MG
PER OS
Not required
JANSSEN CILAG S.A., FRANCE
ANTIPROPULSIVES
Control and symptomatic relief of acute diarrhea in adults, adolescents and children aged 6 years and older.
2021-10-31
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 The medicine is dispensed without a doctor’s prescription This medicine requires a doctor’s prescription in children between the ages of 6 -12 IMODIUM ® CAPSULES ACTIVE INGREDIENT Each capsule contains: Loperamide hydrochloride 2 mg For a list of inactive a nd allergenic ingredients in the product: see section 6 “Further Information”. See also “Important information about some of the ingredients of the medicine” in Section 2. READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to the doctor or pharmacist. This medicine is not intended for children and infants under the age of 6. Use it properly. Consult a pharmacist if you need further information. Refer to a doctor if the signs of the disease (symptoms) worsen or do not improve within 48 hours. 1. WHAT IS THE MEDICINE INTENDED FOR? Imodium is intended for the control and relief of acute diarrhea symptoms in adults, adolescents and children aged 6 years and older. THERAPEUTIC GROUP: Antipropulsive. 2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF: • You are sensitive (allergic) to the active ingredient or to any of the additional ingredients contained in the medicine (that appear in section 6). • Do not use this product in children under 6 years of age. • You have a high fever or bloody stools (signs of acute dysentery). • You are suffering from an inflammation in the intestines such as ulcerative colitis. • You are suffering from constipation or swelling in the abdominal region (especially in children with severe dehydration). • You have diarrhea caused by antibiotic treatment. • You have an intestinal infection caused by a bacterium, such as Salmonella, Shigella or Campylobacter. • You are taking medicines that reduce bowel movements. SPECIAL WARNINGS REGARDING USE OF THE MEDICINE • BEFORE TREATMENT WITH THE MEDICI اقرأ الوثيقة كاملة
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT IMODIUM capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One capsule contains: Active substance: Loperamide hydrochloride 2 mg. Excipients with known effect Lactose monohydrate 127 mg. For the full list of the excipients, see section 6.1. 3. PHARMACEUTICAL FORM Capsules. Opaque green cap and grey body, hard gelatin capsule imprinted with ‘Imodium’ on cap and ‘Janssen’ on body containing white powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS IMODIUM is indicated for control and symptomatic relief of acute diarrhea in adults, adolescents and children aged 6 years and older. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology CHILDREN ABOVE 12 YEARS AND ADULTS The starting dose is 2 capsules (4 mg). Continue treatment with 1 capsule (2 mg), after each loose (soft) stool. The maximum daily dose is 8 capsules per day (16 mg). _SPECIAL POPULATIONS _ CHILDREN AGED BETWEEN 6 AND 12 YEARS (see section 4.3) _ _ The following dosages should not be exceeded: Six to eight years: 2 mg b.i.d. (4mg daily dose) (20 to 30 kg) Eight to twelve years: 2 mg t.i.d. (6mg daily dose) (greater than 30 kg) Following the first treatment day, it is recommended that subsequent IMODIUM doses be administered only after a loose stool. Total daily dosage should not exceed recommended dosages for the first day . The data available regarding the use of loperamide HCl in children under the age of 12 years are limited (see section 4.8 "Undesirable effects"). _ _ ELDERLY No dose adjustment is required in the elderly. _ _ RENAL IMPAIRMENT No dose adjustment is required in patients with impaired renal function. _ _ HEPATIC IMPAIRMENT Although no pharmacokinetic data are available in patients with hepatic impairment, loperamide HCl should be used with caution in these patients due to reduced first-pass metabolism (see section 4.4, "Special warnings and precautions for use"). Method of administration Oral use. The capsules should be taken with liquid. ATTENTION : Do اقرأ الوثيقة كاملة